Pedro David Delgado López

Prof. Dr. Pedro David Delgado López

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2016 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
PLPedro David Delgado López
Pedro David Delgado López
ECE. M. Corrales-García
E. M. Corrales-García

2 March 2017 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
PLPedro David Delgado López
Pedro David Delgado López
ECE. M. Corrales-García
E. M. Corrales-García
JMJ. Martino
J. Martino
ELE. Lastra-Aras
E. Lastra-Aras
MDM. T. Dueñas-Polo
M. T. Dueñas-Polo


1 May 2017 in Neurocirugia
Verified
Journal Article
Closed access
PLPedro David Delgado López
Pedro David Delgado López
ARAntonio Rodríguez-Salazar
Antonio Rodríguez-Salazar
JMJavier Martín-Alonso
Javier Martín-Alonso
VMVicente Martín-Velasco
Vicente Martín-Velasco

19 December 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ECEsther Cubo
Esther Cubo
PLPedro David Delgado López
Pedro David Delgado López
Background: As the global population grows, there is an increasing demand for neurologic consultation that prompts new ways to reach more patients. Telemedicine can provide an accessible, cost-effective, and high-quality healthcare services. Objectives: In this article, we highlight recent developments, achievements, and challenges regarding outcomes, clinical care, tele-education, teletreatment, teleresearch, and cybersecurity for telemedicine applied to Parkinson´s disease (PD) and other neurological conditions. Results: A growing body of evidence supports the feasibility and effectiveness of telemedicine tools for PD and other movement disorders. Outcome variables regarding satisfaction and efficacy in clinical care and specific issues about education, research, and treatment are reviewed. Additionally, a specific legal framework for teleconsultation has been developed in some centers worldwide. Yet, the implementation of telemedicine is conditioned by the limitations inherent to remote neurological examination, the variable computer usage literacy among patients, and the availability of a reliable internet connection. At present, telemedicine can be considered an additional tool in the clinical management of PD patients. Conclusions: There is an increasing use of remote clinical practice regarding the management of PD and other neurological conditions. Telemedicine is a new and promising tool aimed at special settings and subpopulations.

5 April 2018 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
PLPedro David Delgado López
Pedro David Delgado López
JPJ. Pi-Barrio
J. Pi-Barrio
MDM. T. Dueñas-Polo
M. T. Dueñas-Polo
MPM. Pascual-Llorente
M. Pascual-Llorente
MGM. C. Gordón-Bolaños
M. C. Gordón-Bolaños